Ashley Shoemaker Archive — Page 1 of 1

Top-down view of socked feet standing on a glass bathroom scale against a blue background; the display is blank or unreadable.
February 10, 2022

New insights into hypothalamic obesity

A common Type 2 diabetes treatment being tested for hypothalamic obesity had unexpected results on weight loss and total energy expenditure, Vanderbilt researchers report.

By Elliot Jaffe
A transparent medical syringe is embedded diagonally in the bullseye of a black-and-yellow dartboard. Measurement markings are visible on the syringe.
November 3, 2020

New treatment for a rare obesity

Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.

By Bill Snyder
August 9, 2018

Kropski, Shoemaker honored by Doris Duke Foundation

Two early-career physician-scientists at Vanderbilt University Medical Center are among 18 recipients of 2018 Clinical Scientist Development Awards announced July 31 by the Doris Duke Charitable Foundation.

By Bill Snyder
Blue side profile of a human head silhouette containing interlocking colorful gears, symbolizing brain function and the workings of the human body.
February 13, 2018

Cognition in rare hormonal disorder

Vanderbilt investigators have conducted the first systematic evaluation of cognitive function in children with a rare genetic disorder.

By Leigh MacMillan
Four women stand together indoors, identified in the caption as Cassie Brady, Ashley Shoemaker, Sharon Karp, and Tamasyn Nelson, directors of the Vanderbilt Pre-Diabetes Clinic.
June 22, 2017

Vanderbilt Pre-Diabetes Clinic tackles type 2 diabetes in children

In Middle Tennessee, where roughly one-third of children are overweight or obese, the risk of developing pediatric type 2 diabetes is high and the consequences can be serious.

By Meredith Jackson